Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

Writer, Stock Market Wire
Tuesday, February 12, 2019 - 13:00

HSBC today initiates coverage of Dechra Pharmaceuticals PLC (LON:DPH) with a buy investment rating and price target of 2770p.

Broker Forecasts data provided by www.sharesmagazine.co.uk


Related content

Dechra's Richard Cotton steps down as CFO for 'personal reasons'

Dechra said Richard Cotton, Chief Financial Officer, would leave the company immediately for 'personal reasons'.

'The Board has agreed that with immediate effect Richard...

Wed, 03/04/2019 - 07:44


Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2805p (from 2466p).

Broker Forecasts data...

Mon, 25/03/2019 - 12:50


Broker Forecast - JP Morgan Cazenove issues a broker note on Dechra Pharmaceuticals PLC

JP Morgan Cazenove today initiates coverage of Dechra Pharmaceuticals PLC (LON:DPH) with a overweight investment rating and price target of 3000p.

Broker Forecasts data provided...

Mon, 25/03/2019 - 09:10


Broker Forecast - HSBC issues a broker note on Dechra Pharmaceuticals PLC

HSBC today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 2700p (from 2770p).

Broker Forecasts data provided...

Mon, 11/03/2019 - 11:40


Dechra pharmaceuticals underlying profit rises, led by North America

Dechra Pharmaceuticals, which develops drugs for animals, reported Monday first-half results that met its expectations, led by strong growth in its North American division.

For...

Mon, 25/02/2019 - 16:25